Horizontal Cell Hyperpolarization for Retinal Contrast Encoding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current models of center-surround organization in the retina are based on competitive antagonism, which is challenged by data showing that contrast encoding is relative to the surrounding context, and existing treatments for retinal degeneration fail to effectively improve vision by targeting horizontal cells without disrupting remaining vision.
Innovation Solution
The use of a nucleic acid molecule to hyperpolarize horizontal cells, specifically through expression constructs and vectors targeting horizontal cells, to adjust the operating range of rod and cone photoreceptors, improving vision by mimicking natural light input and lateral adaptation mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional competitive antagonism model is applied to center-surround organization, then contrast enhancement is achieved, but the model fails to account for relative contrast encoding and adaptive luminance tuning
Solution Approach 1:
The patent inverts the conventional understanding by showing that horizontal cells do not create contrast enhancement through competitive antagonism, but rather enable relative contrast encoding through adaptive luminance tuning. The surround does not enhance center contrast but sets the luminance context that defines the operating range for contrast detection, fundamentally reversing the traditional center-surround functional model.
Solution Approach 2:
The patent demonstrates that horizontal cells dynamically adjust the operating luminance range of photoreceptors based on surround luminance levels. This parameter change allows the visual system to adapt contrast sensitivity across different illumination conditions (mesopic to photopic ranges), resolving the contradiction between precise contrast encoding and luminance adaptability.
2Reliability
If horizontal cells are targeted to improve vision in retinal degeneration, then rod photoreceptor sensitivity is enhanced, but remaining vision may be disrupted
Solution Approach 1:
The patent applies local quality by selectively targeting horizontal cells that provide lateral input to rod photoreceptors, while preserving the function of horizontal cells serving cone photoreceptors. This localized intervention enhances rod sensitivity in peripheral vision without disrupting cone-mediated central vision, thereby improving overall visual function without harmful side effects.
Solution Approach 2:
The patent uses horizontal cells as an intermediary mechanism to indirectly enhance rod photoreceptor function. Rather than directly stimulating rods or suppressing their inhibition, the invention modulates horizontal cell activity to naturally adjust rod operating ranges, providing a safe and physiologically appropriate method for improving vision in retinal degeneration.
3Measurement precision
If rod photoreceptors are activated at mesopic light levels, then sensitivity is improved, but rods naturally saturate and cannot function effectively in brighter light
Solution Approach 1:
The patent implements dynamics by making rod photoreceptor sensitivity可调 (adjustable) through lateral input from horizontal cells. The operating range of rods is dynamically shifted based on surround luminance levels, allowing rods to function at higher light levels when needed while maintaining their natural high sensitivity. This dynamic adjustment resolves the contradiction between sensitivity and light level adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances contrast sensitivity and visual acuity, particularly in conditions like macular degeneration and achromatopsia, by making rod photoreceptors more cone-like at mesopic light levels, potentially offering a therapeutic benefit for retinal dystrophies without causing visual side effects.
Implementation Method 1
Photons hitting a photoreceptor are transduced into an electrical signal
Implementation Method 2
Horizontal cells are laterally-projecting interneurons that provide feedback and feedforward signals to photoreceptors and bipolar cells respectively
Implementation Method 3
expression of the gene product in horizontal cells improves vision
Data Source
AI summary
The present invention relates to methods of improving vision. Specifically, the invention relates to the use of a nucleic acid molecule to activate (hyperpolarize) horizontal cells in the mesopic and photopic illumination ranges and the use of said nucleic acid molecule to improve visual function, for example following degeneration or loss of the ‘macula’.